首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Authors:Martin E Gore  Cezary Szczylik  Camillo Porta  Sergio Bracarda  Georg A Bjarnason  Stéphane Oudard  Subramanian Hariharan  Se-Hoon Lee  John Haanen  Daniel Castellano  Eduard Vrdoljak  Patrick Schöffski  Paul Mainwaring  Alejandra Nieto  Jinyu Yuan  Ronald Bukowski
Affiliation:1. Royal Marsden Hospital NHS Trust, London, UK;2. Military Medical Institute, Oncology, Warsaw, Poland;3. IRCCS San Matteo University Hospital Foundation, Pavia, Italy;4. Azienda Ospedaliera di Perugia, Perugia, Italy;5. Sunnybrook Odette Cancer Centre, Toronto, Canada;6. Hôpital Européen Georges Pompidou, Paris, France;7. Pfizer Oncology, New York, NY, USA;8. Seoul National University Hospital, Seoul, South Korea;9. The Netherlands Cancer Institute, Amsterdam, Netherlands;10. Hospital Universitario 12 de Octubre, Madrid, Spain;11. University Hospital Split, Split, Croatia;12. University Hospitals Leuven, Leuvan Cancer Institute, Catholic University Leuven, Leuven, Belgium;13. Mater Adult Hospital, Brisbane, QLD, Australia;14. Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号